Lanetik

Enalapril maleate, the active ingredient in Lanetik, is an ACE inhibitor presented as a tablet for oral use. It is combined with hydrochlorothiazide, a thiazide diuretic, to treat hypertension in adult patients requiring dual therapy to control blood pressure.

GNH USA supplies Lanetik as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide with assured quality, regulatory adherence and reliable logistics for global distribution. All batches are manufactured under EU GMP guidelines and undergo stringent release testing.

Lanetik combines an ACE inhibitor and a thiazide diuretic to address conditions within the hypertension disease family.

Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. Essential hypertension: provides additional blood‑pressure control when monotherapy is insufficient. Heart failure: assists in reducing afterload and fluid overload when combined therapy is indicated. Edema associated with hypertension: promotes diuresis to reduce fluid retention.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after standing. - Headache. - Increased urination. - Fatigue. - Electrolyte changes such as mild potassium loss.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure. - Acute renal impairment or failure. - Hyperkalemia: elevated potassium levels. - Pancreatitis (rare).

Before initiating therapy, clinicians should consider the following precautions: - Monitor blood pressure regularly: ensure target levels are achieved without excessive drop. - Assess renal function: adjust dose in patients with impaired kidney function. - Check electrolytes: watch for sodium, potassium, and chloride abnormalities. - Avoid use in pregnancy: ACE inhibitors are contraindicated during the second and third trimesters. - Use caution with NSAIDs: may reduce antihypertensive efficacy and affect renal function. - Adjust in diabetes: monitor glucose and renal parameters closely. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lanetik may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Lithium: increased lithium levels and toxicity. - Aliskiren (in diabetics): heightened risk of renal impairment and hypotension. - NSAIDs: may blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Other antihypertensives (beta‑blockers, calcium channel blockers): additive blood‑pressure lowering. - Antacids containing aluminum or magnesium: may reduce absorption of enalapril. - Rifampin or other enzyme inducers: may decrease plasma concentrations of enalapril.